Hidoc Dr | Medical Learning App for Doctors

Today's Updates

UK Lawmakers Reject Bid to Legalise Assisted Dying

Published Date: 12 Sep 2026

British lawmakers rejected on Friday a proposal to legalise assisted dying for terminally ill people, dealing a major setback to campaigners and bringing the latest effort...

Liberalized Cannabis Policies May Increase Substance Use

Published Date: 12 Sep 2026

In a global review, legalization was associated with increased cannabis use and related emergency department visits, with potential decreases in the use of alcohol and tobacco.

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Published Date: 12 Sep 2026

Researchers analyzed plasma samples collected from 313 patients with early breast cancer approximately 2 years after they had completed adjuvant chemotherapy.

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

Published Date: 12 Sep 2026

Patients who respond to neoadjuvant immunochemotherapy may be able to undergo less extensive surgery, with high rates of disease control and organ preservation.

TKI Discontinuation Feasible After ALL Treatment

Published Date: 12 Sep 2026

In patients with first- or second-line Philadelphia-positive B-cell acute lymphoblastic leukemia, favorable outcomes are observed with discontinuation of ponatinib.

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

Published Date: 12 Sep 2026

For patients with early-stage, inoperable lung cancer, adding atezolizumab to standard radiotherapy boosts toxicity, not survival.

Knowledge Hub

Oncology

Screening for Cancer-Treatment-Related Bone Loss: Clinical Implications and Evidence-Based Strategies

Comprehensive review of screening and management strategies for cancer-treatment-related bone loss.

Oncology

Targeted Degradation in Breast Cancer: Mechanisms, Clinical Applications, and Future Perspectives

Comprehensive review of targeted protein degradation strategies in breast cancer, mechanisms, clinical impact, and future advances.

Oncology

Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches

Comprehensive review of near-misses in oncology drug handling, covering risks, mechanisms, prevention, and guidelines for healthcare professionals.

Oncology

Molecular Glues for Solid Tumors: Mechanistic Insights, Clinical Relevance, and Therapeutic Potential

A comprehensive review of molecular glues for solid tumors, highlighting mechanisms, clinical relevance, and emerging therapeutic advances.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

UK Lawmakers Reject Bid to Legalise Assisted Dying

Liberalized Cannabis Policies May Increase Substance Use

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

TKI Discontinuation Feasible After ALL Treatment

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

Knowledge Hub

Screening for Cancer-Treatment-Related Bone Loss: Clinical Implications and Evidence-Based Strategies

Targeted Degradation in Breast Cancer: Mechanisms, Clinical Applications, and Future Perspectives

Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches

Molecular Glues for Solid Tumors: Mechanistic Insights, Clinical Relevance, and Therapeutic Potential

Therapeutic RNA Vaccines for Cancer: Mechanisms, Clinical Applications, and Future Directions

Exercise Capacity During Cancer Recovery: Clinical Evidence, Mechanisms, and Practical Implications

Preventing Sarcopenia During Cancer Treatment

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

UK Lawmakers Reject Bid to Legalise Assisted Dying

Liberalized Cannabis Policies May Increase Substance Use

Tissue-Free ctDNA Predicts Recurrence in Early Breast Cancer

Can Response-Adapted Surgery Improve Outcomes in HNSCC?

TKI Discontinuation Feasible After ALL Treatment

SBRT Plus Atezolizumab Shows No Benefit in Inoperable NSCLC

Knowledge Hub

Screening for Cancer-Treatment-Related Bone Loss: Clinical Implications and Evidence-Based Strategies

Targeted Degradation in Breast Cancer: Mechanisms, Clinical Applications, and Future Perspectives

Oncology Drug Handling Near-Misses: Clinical Risks, Pathophysiology, and Guideline-Based Approaches

Molecular Glues for Solid Tumors: Mechanistic Insights, Clinical Relevance, and Therapeutic Potential

Therapeutic RNA Vaccines for Cancer: Mechanisms, Clinical Applications, and Future Directions

Exercise Capacity During Cancer Recovery: Clinical Evidence, Mechanisms, and Practical Implications

Preventing Sarcopenia During Cancer Treatment

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views